The global orthopedic implants in biomaterials market is poised for robust growth, driven by an aging global population, increased prevalence of osteoporosis and osteoarthritis, and advancements in implant technologies. According to Markets, the market is predicted to reach around $64.0 billion by 2027, at a CAGR of approximately 4.6% from 2022 to 2027. The growing popularity of minimally invasive surgeries and the rise of 3D-printing in orthopedics are significant growth factors. However, the market faces hurdles like strict regulatory scrutiny and the high cost of procedures. Emerging markets, personalized orthopedic implants, and bioabsorbable implants in biomaterials are seen as potential growth opportunities.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by